Dual-targeted therapy with trastuzumab and lapatinib in treatment-refractory, KRAS codon 12/13 wild-type, HER2-positive metastatic colorectal cancer (HERACLES): a proof-of-concept,... by Sartore-Bianchi, Andrea, MD, Trusolino, Livio, MD, Martino, Cosimo, PhD, Bencardino, Katia, MD, Lonardi, Sara, MD, Bergamo, Francesca, MD, Zagonel, Vittorina, MD, Leone, Francesco, MD, Depetris, Ilaria, MD, Martinelli, Erika, MD, Troiani, Teresa, MD, Ciardiello, Fortunato, Prof, Racca, Patrizia, MD, Bertotti, Andrea, MD, Siravegna, Giulia, MSc, Torri, Valter, MD, Amatu, Alessio, MD, Ghezzi, Silvia, MSc, Marrapese, Giovanna, PhD, Palmeri, Laura, MD, Valtorta, Emanuele, PhD, Cassingena, Andrea, MSc, Lauricella, Calogero, PhD, Vanzulli, Angelo, MD, Regge, Daniele, MD, Veronese, Silvio, MSc, Comoglio, Paolo M, Prof, Bardelli, Alberto, PhD, Marsoni, Silvia, Dr, Siena, Salvatore, Prof

Get full text